Related references
Note: Only part of the references are listed.Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century
Dianne Pulte et al.
BLOOD (2009)
Optimal management of adults with ALL
Jacob M. Rowe
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia
Christine J. Harrison
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Epidemiology of leukaemia and lymphoma in children and young adults from the north of England, 1990-2002
Richard G. Feltbower et al.
EUROPEAN JOURNAL OF CANCER (2009)
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
Wendy Stock et al.
BLOOD (2008)
Patients' age and BCR-ABL frequency in adult B-precursor ALL:: a retrospective analysis from the GMALL study group
Thomas Burmeister et al.
BLOOD (2008)
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Charles G. Mullighan et al.
NATURE (2008)
Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease
Kajsa Paulsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study
Vinod Pullarkat et al.
BLOOD (2008)
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
Anthony H. Goldstone et al.
BLOOD (2008)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial
Anthony V. Moorman et al.
BLOOD (2007)
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Charles G. Mullighan et al.
NATURE (2007)
Adolescents with acute lymphoblastic leukaemia: Outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials
Ramya Ramanujachar et al.
PEDIATRIC BLOOD & CANCER (2007)
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
Adele K. Fielding et al.
BLOOD (2007)
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia
DA Thomas et al.
CANCER (2006)
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL):: analysis of the GIMEMA 0496 protocol
M Mancini et al.
BLOOD (2005)
Mechanisms of disease: Acute lymphoblastic leukemia
C Pui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands
JM de Bont et al.
LEUKEMIA (2004)
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults?: Comparison of the French FRALLE-93 and LALA-94 trials
N Boissel et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
